| Filed On | Filing |
|---|---|
| 09 May 2025 |
8-K/A: Financial Statements and Exhibits
On December 19, 2024, the OraSure Technologies, Inc. (the “Company”) acquired Sherlock Biosciences, Inc. (“Sherlock”), pursuant to the terms of a merger agreement (the “Merger”). In connection with the Merger, Sherlock merged with and in... |
| 07 Mar 2025 |
8-K/A: Financial Statements and Exhibits
On December 19, 2024, the OraSure Technologies, Inc. (the “Company”) acquired Sherlock Biosciences, Inc. (“Sherlock”), pursuant to the terms of a merger agreement (the “Merger”). In connection with the Merger, Sherlock merged with and in... |
| 02 Aug 2023 |
8-K/A: Submission of Matters to a Vote of Security Holders
(d) As previously disclosed in the Original Form 8-K, in a non-binding advisory vote on the frequency of future say-on-pay votes held at the 2023 Annual Meeting, 55,752,085 shares voted for one year, 65,308 shares voted for two years, 3,... |
| 15 Jul 2022 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously disclosed, on May 23, 2022, Kathleen G. Weber, who currently serves as the Company’s President of Molecular Solutions, notified the Company of her intention to resign from the Company, effective August 21, 2022. |
| 04 Oct 2018 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 02 Nov 2011 | 8-K/A: Financial Statements and Exhibits |
Loading...
